IPO Readiness IVC Evidensia is positioned for an IPO with strong EQT backing and ongoing expansion of leadership in Europe and Canada. The appointment of a CEO for VetStrategy Canada and regional CEOs for Northern and Central Europe signals a scalable, multi country operation. This presents opportunities to offer IPO readiness services, governance and compliance programs, financial systems integration, and contract lifecycle management to support growth and investor reporting.

Cross Border Expansion Across Northern Europe, Central Europe and Canada the company is expanding across many markets, creating needs for multi country ERP, localized regulatory compliance, centralized procurement and supplier management. A large, distributed clinic network implies demand for scalable practice management, data integration and language localization. VetStrategy Canada emerges as a potential partner for cross border expansion and bundled corporate services such as IT, procurement and payroll.

IT Modernization Leadership changes including a recent Global CIO departure combined with a sizable tech footprint indicate a strong opportunity to accelerate IT modernization. The existing stack includes Azure Edge Network, DocuSign and Nginx, suggesting scope for cybersecurity enhancement, cloud consolidation, enterprise data platforms and AI driven insights for animal health. Position as a partner for managed services, systems integration and data analytics to support daily operations and IPO readiness.

Talent and Culture The recognition as a Top Employer in the UK and ongoing executive hires reflect a focus on talent and culture. This creates demand for HR technology, payroll across multiple countries, learning and development platforms and employee engagement tools. Potential to partner on HRIS implementations, recruitment process outsourcing and regional benefits programs for a 1000 plus workforce.

Strategic Partnerships Backed by a large private equity investor, strong brand and a competitive landscape with NVA and AniCura, IVC Evidensia is well positioned for strategic partnerships in procurement, veterinary equipment, and pharmaceutical supply. The upcoming IPO further increases appetite for centralized purchasing programs, supplier risk management and marketing technology to strengthen market position. This presents cross sell opportunities for software, services and digital marketing collaborations across clinics and corporate offices.